Match tier Likely match
Presence Current · Arkansas
Last published 2025
Sources OpenAlex · ORCID
Refreshed 2026-08-15

Jing Liu

This is a likely match — the affiliation was inferred from OpenAlex, ORCID, and web sources but has not been fully confirmed. Treat with appropriate caution.

postdoc research fellow

Also affiliated: Rutgers, The State University of New Jersey (2003–2006); Ningbo University (2013–2017); University of East Anglia (2019); University of Iowa (2017); Brigham and Women's Hospital (2019–2023); Beth Israel Deaconess Medical Center (2021–2025); Union Hospital (2017–2024); Harvard University (2005–2024); Central South University (2023–2024); University of Kentucky (2010–2015); Shandong University (2021); Harbin Medical University (2021); Jinan University (2013–2018); Shanxi Medical University (2019); Pfizer (United States) (2005–2016); Shanghai Jiao Tong University (2014); Chinese Academy of Sciences (2017); Chinese Academy of Medical Sciences & Peking Union Medical College (2020–2021); Medical College of Wisconsin (2015–2022); Washington University in St. Louis (2022); Hainan University (2025); Nanjing General Hospital of Nanjing Military Command (2015); McLean Hospital (2016–2019); Beth Israel Deaconess Hospital (2024); Chinese PLA General Hospital (2021–2025); Shantou University (2014); Massachusetts General Hospital (2005–2013); Xian Center for Disease Control and Prevention (2022); Cancer Hospital of Shantou University Medical College (2014); Affiliated Hospital of Hangzhou Normal University (2022); Zhongda Hospital Southeast University (2013); Hainan Provincial Academy of Marine Fisheries and Aquaculture (2025); Institute of Biophysics (2017); Gansu Provincial Hospital (2017); Shantou University Medical College (2014); First Affiliated Hospital of GuangXi Medical University (2021); Athinoula A. Martinos Center for Biomedical Imaging (2005–2013); Shanghai East Hospital (2022); Wuhan Union Hospital (2014–2018); Stem Cell Institute (2009); Heze Municipal Hospital (2021); Wuhan Children's Hospital (2022); Beijing Children’s Hospital (2022); Second Xiangya Hospital of Central South University (2023–2024); First Affiliated Hospital of Harbin Medical University (2021); Huazhong University of Science and Technology Hospital (2018); Tongji Hospital (2009–2016); Union Hospital (2014–2021); University of Chinese Academy of Sciences (2017); Dezhou University (2020); Rutgers New Jersey Medical School (2003–2006); Inner Mongolia Medical University (2019); Huazhong University of Science and Technology (2009–2025); Mass General Brigham (2003); Southeast University (2025); University of California, Davis (2009); Nanjing University (2015–2025); China Medical University (2015)

Postdoc Researcher

34 h-index 113 pubs 4,460 cited

Upstream record may be merged OpenAlex, the source of these figures, lists 59 institutions in 4 countries for this author record — a pattern that usually means it combines several researchers with similar names. The totals above may include work by other people.

  • Animals
  • Humans
  • Mice
  • Male
  • Mice, Inbred C57BL
  • Female
  • Disease Models, Animal
  • Signal Transduction
  • Mice, Knockout
  • Myocytes, Cardiac
  • Rats
  • Cells, Cultured
  • Myocardium
  • Atherosclerosis
  • Apoptosis

Biography and Research Information

OverviewAI-generated summary

Jing Liu's research focuses on understanding the molecular mechanisms underlying various disease states, with a particular emphasis on cardiovascular health, immune responses, and metabolic pathways. Liu has investigated the role of heme in promoting cardiac ferroptosis in sickle cell disease models and explored how Lcz696 alleviates myocardial fibrosis by modulating the sFRP-1/Wnt/β-catenin signaling pathway. Further work has examined the impact of circulating hemopexin on anthracycline-induced cardiac toxicity in both preclinical models and human patients. Liu has also contributed to understanding therapeutic interventions for pulmonary arterial hypertension, silicosis, and cardiac recovery post-myocardial infarction, exploring pathways involving prostaglandins, Nrf2/HO-1, and mesenchymal stem cell-mediated signaling.

Additional research areas include the protective roles of Group 2 innate lymphoid cells and eosinophils in conditions such as abdominal aortic aneurysm formation and cardiac hypertrophy. Liu's scholarship metrics include an h-index of 34, with 113 total publications and 4,410 total citations. Liu has collaborated with researchers including Andrew N. J. McKenzie at the University of Arkansas for Medical Sciences, and Soumya Pandey, Shikha Pandey, and E.M. Fore at the University of Arkansas for Medical Sciences.

Metrics

  • h-index: 34
  • Publications: 113
  • Citations: 4,460

Selected Publications

  • Virtual crossmatch compatible, with unexpected fluorescence cytometric crossmatch positive, may be safe to proceed with transplantation under certain circumstances (2025)
    Human Immunology DOI OpenAlex
  • Uncovering the rarity: DR7-DR53-DQ9 haplotype in two Caucasian patients (2024)
    Human Immunology DOI OpenAlex
  • P504 Differentiating among allele-specific antibodies is important for a successful heart transplantation (2023)
    Human Immunology DOI OpenAlex
  • P526 CREG associations and epitope analyses should not be overlooked when performing virtual crossmatch (2023)
    Human Immunology DOI OpenAlex

View all publications on OpenAlex →

Collaboration Network

4 Collaborators 1 Institution 1 Country

Top Collaborators

View profile →
View profile →
View profile →
View profile →

Similar Researchers

Based on overlapping research topics